Variant report
Variant | esv989435 |
---|---|
Chromosome Location | chr2:173004125-173009154 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536499472 | chr2:173004178-173004179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs142066702 | chr2:173004207-173004208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76594310 | chr2:173004224-173004225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566922368 | chr2:173004226-173004227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78505568 | chr2:173004227-173004228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201261357 | chr2:173004233-173004234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369108005 | chr2:173004238-173004239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79648668 | chr2:173004239-173004240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577258428 | chr2:173004240-173004241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538241030 | chr2:173004264-173004265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556489408 | chr2:173004265-173004266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575502770 | chr2:173004269-173004270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542525339 | chr2:173004273-173004274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561160366 | chr2:173004274-173004275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572932340 | chr2:173004287-173004288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79886888 | chr2:173004317-173004318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78550885 | chr2:173004326-173004327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532598667 | chr2:173004334-173004335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs117050214 | chr2:173004419-173004420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77107098 | chr2:173004443-173004444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530443206 | chr2:173004557-173004558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189054564 | chr2:173004565-173004566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182044090 | chr2:173004613-173004614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527869062 | chr2:173004620-173004621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546335274 | chr2:173004621-173004622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571012694 | chr2:173004662-173004663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187654348 | chr2:173004768-173004769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376887377 | chr2:173004784-173004785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13396256 | chr2:173004862-173004863 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs143991342 | chr2:173004918-173004919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536578030 | chr2:173004979-173004980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs72625238 | chr2:173005061-173005062 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs148703556 | chr2:173005079-173005080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs141341448 | chr2:173005088-173005089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190757998 | chr2:173005131-173005132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577426873 | chr2:173005136-173005137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs180899108 | chr2:173005172-173005173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562926478 | chr2:173005212-173005213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs72625239 | chr2:173005230-173005231 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs72879560 | chr2:173005261-173005262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186181404 | chr2:173005274-173005275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190298803 | chr2:173005305-173005306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs79251258 | chr2:173005342-173005343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552545649 | chr2:173005432-173005433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs4484004 | chr2:173005433-173005434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370866150 | chr2:173005450-173005451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550241442 | chr2:173005480-173005481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139431714 | chr2:173005492-173005493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs535862106 | chr2:173005506-173005507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542751220 | chr2:173005510-173005511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Prostate cancer | 16573809 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Donnai-Barrow syndrome | 21085971 | CNVD |
Breast cancer | 21045282 | CNVD |
Limb abnormalities | 22140379 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:173002200-173012600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:173004400-173007200 | Weak transcription | Fetal Brain Male | brain |
3 | chr2:173006400-173006800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr2:173006600-173007000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:173006600-173012600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr2:173006800-173010600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr2:173008800-173009000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr2:173008800-173009200 | Enhancers | Brain Germinal Matrix | brain |
9 | chr2:173009000-173009200 | Enhancers | Cortex derived primary cultured neurospheres | brain |